Stenberg VY, Liukaityte R, Kristiansen SK, Wangen-Riise R, Kleinauskas A, Dunne V, Juzeniene A(2025) Cytotoxicity and cell cycle changes in prostate cancer cells with differing PSMA expression and p53 status after treatment with PSMA-targeting radioligand [212Pb]Pb-AB001 Sci Rep(in press) DOI 10.1038/s41598-025-29785-7, PubMed 41318731
Li Y, Li X, Li X, Zhong Y, Ji Y, Yu D, Zhang M, Wen JG, Zhang H, Goscinski MA, Nesland JM, Suo Z(2025) Retraction: PDHA1 gene knockout in prostate cancer cells results in metabolic reprogramming towards greater glutamine dependence Oncotarget, 16, 790 DOI 10.18632/oncotarget.28777, PubMed 41201955
Bolli N, D'Agostino M, Bagratuni T, Boccadoro M, Cavo M, Driessen C, Einsele H, Engelhardt M, Gay F, Gutiérrez NC, Hájek R, Holien T, João C, Kaiser M, Kortüm KM, Leypoldt L, Moreau P, Musto P, Ocio EM, Raab MS, Rasche L, Schjesvold F, Sevcikova T, Terpos E, Touzeau Cet al.(2025) European Myeloma Network Group Consensus Statement on the use of next-generation sequencing for prognostic stratification of newly diagnosed multiple myeloma Hemasphere, 9(10), e70216 DOI 10.1002/hem3.70216, PubMed 41089883
